Agpar 125mg/5ml Suspension

Introduction

Agpar is a medication that contains the active ingredient Paracetamol. It is available in a suspension form and is commonly used to provide relief from pain and reduce fever. Paracetamol is a widely recognized and trusted medication that has been used for many years to manage various conditions.

Uses

Agpar is prescribed to treat mild to moderate pain, such as headaches, toothaches, muscle aches, and menstrual cramps. It is also commonly used to reduce fever associated with infections, such as the common cold or flu.

Dosage and Administration

The dosage of Agpar depends on the age and weight of the patient. Follow the instructions provided by your healthcare provider or follow the guidelines on the product packaging. The suspension should be shaken well before use and can be taken with or without food. It is usually administered orally using the provided measuring device, such as a dropper or spoon.

Mechanism of Action

The active ingredient in Agpar, Paracetamol, works by inhibiting the production of certain chemicals in the body that are responsible for pain and fever. It acts on the central nervous system to provide pain relief and on the hypothalamus to reduce fever.

Side Effects

Common side effects may include nausea, vomiting, upset stomach, and allergic reactions such as skin rash or itching. These side effects are usually mild and resolve on their own. However, if you experience any serious side effects, such as difficulty breathing, swelling, or signs of liver problems (such as dark urine or yellowing of the skin/eyes), seek medical attention immediately.

Drug Interactions

Agpar may interact with other medications, including certain antibiotics, anticoagulants, and medications that affect liver function. Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before taking Agpar, inform your healthcare provider if you have any known allergies, liver problems, or if you are pregnant or breastfeeding. Avoid consuming alcohol while taking this medication, as it can increase the risk of liver damage. Agpar should not be taken in higher doses or for longer durations than recommended, as this can lead to serious side effects.

Storage

Agpar should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and out of reach of children.

Patient Tips

• Always follow the recommended dosage and administration instructions provided by your healthcare provider or on the packaging.
• If you are unsure about the appropriate dose for you or your child, consult your healthcare provider.
• If the symptoms persist or worsen, or if new symptoms occur, seek medical advice.
• Keep track of the medications you are taking and inform your healthcare provider about all the medications, including over-the-counter drugs and herbal supplements.
• Do not exceed the recommended dose of Agpar, as it may cause serious side effects.
• If you accidentally take a higher dose than recommended, seek medical attention immediately.
• Store the medication in a safe place, away from children and pets.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Paracetamol for adults: painkiller for pain and high temperature (NHS UK) [Accessed 17 Jun. 2024] (online) Available at:
• Alka-Seltzer XS (Health Professionals SmPC) Available at:
• Paracetamol (Drugs.com) [Accessed 18 Jun. 2024] (online) Available at:
• paracetamol tablet (OTC) [Accessed 9 Jun. 2024] (online) Available at:
• Acetaminophen Level: MedlinePlus Medical Test (MedlinePlus) [Accessed 23 Jun. 2024] (online) Available at: acetaminophen-level” rel=”noreferrer noopener” target=”_blank”>
• Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014 Jan-Feb;71(1):11-23. [Accessed 27 Jun. 2024] Available at: